Princeton Capital Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
MG
HF
NCM
Princeton Capital Management's XPH Position: Q2 2015 in Review
Princeton Capital Management sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2015, closing a stake of 3,374 shares — an estimated $208K sold.
Princeton Capital Management first reported a position in XPH in Q1 2015 and held it in 1 quarter. The position peaked at $208K in Q1 2015. 85 funds tracked by Wall St. Rank hold XPH as of Q2 2015.
- Princeton Capital Management reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q2 2015 after selling out during the quarter.
- Princeton Capital Management sold 3,374 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2015, an estimated $208K.
- Princeton Capital Management first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2015 and held it in 1 quarter.
- Princeton Capital Management's State Street SPDR S&P Pharmaceuticals ETF position peaked at $208K in Q1 2015.
- 85 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2015.
Based on Princeton Capital Management's 13F filing for Q2 2015, filed 23 Jul 2015.